A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors (Q84660472)

From Wikidata

Jump to navigation Jump to search

scientific article published on 03 August 2011

Language	Label	Description	Also known as
English	A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors	scientific article published on 03 August 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

ChEBI release 2020-05-28

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Elisabeth I Heath

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Karen Forman

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Lisa Malburg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Shelby Gainer

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

A Benjamin Suttle

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Laurel Adams

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Howard Ball

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Patricia LoRusso

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

3 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1566-1574

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21811833%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

https://scigraph.springernature.com/pub.10.1007/s10637-011-9725-2

0 references

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of the pharmacokinetic and safety profiles of oral pazopanib with a high-fat or low-fat meal in patients with advanced solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of pazopanib in patients with advanced cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does mixing pancreatic enzyme microspheres (Pancrease) with food damage the enteric coating?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pazopanib: a novel multitargeted tyrosine kinase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21811833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84660472&oldid=2143675297"